uk-50001

CAS No. 857900-47-1

uk-50001( —— )

Catalog No. M36004 CAS No. 857900-47-1

uk-50001 is a phosphodiesterase (PDE) 4 inhibitor that can be used for many diseases, especially inflammation, allergies, respiratory diseases, disorders and conditions and wounds.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 470 In Stock
5MG 380 In Stock
10MG 570 In Stock
25MG 911 In Stock
50MG 1190 In Stock
100MG 1628 In Stock
200MG Get Quote In Stock
500MG 3246 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    uk-50001
  • Note
    Research use only, not for human use.
  • Brief Description
    uk-50001 is a phosphodiesterase (PDE) 4 inhibitor that can be used for many diseases, especially inflammation, allergies, respiratory diseases, disorders and conditions and wounds.
  • Description
    uk-50001 is a phosphodiesterase (PDE) 4 inhibitor that can be used for many diseases, especially inflammation, allergies, respiratory diseases, disorders and conditions and wounds.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    857900-47-1
  • Formula Weight
    499.48
  • Molecular Formula
    C26H24F3N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C1=C(C(NC2CCC(NC(=O)C3=C(O)C=CC(C)=C3)CC2)=O)C=C(F)C=N1)C4=CC(F)=C(F)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Imazodan

    Imazodan, a small molecule compound with positive inotropic activity, is a selective type III phosphodiesterase inhibitor and can be used to study heart failure.

  • Difamilast

    Difamilast (OPA-15406) is a novel potent, selective phosphodiesterase IV (PDE4) inhibitor with preference for PDE4B (IC50=11.2 nM).?

  • AWD 12-281

    AWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD).